OUR EXPERTISE

Certifications

All American Pharmaceutical has earned the following certifications:

The Informed-Sport Registered Site program provides assurance that the facility is equipped with adequate critical control procedures to minimise the risk of contamination within the facility for substances prohibited in sport.

The Informed-Choice Site Registration is a unique certification that provides indepth analysis into critical control processes. Through regular on-site inspections and manufacturing facility swabbing, the Informed-Choice Registered Site program helps manufacturers identify and resolve areas of risk within the manufacturing process.

The Informed Manufacturer program was developed to minimize the risk of banned substance contamination within the facilities that manufacture and supply sports nutrition products and ingredients. Certification allows third-party manufacturers to clearly communicate to their customers - the sports supplement brands - that their facility meets high-quality control standards and has been assessed to minimize the risk of contamination with banned substances.

Good Manufacturing Practices (GMPs) are guidelines that provide a system of processes, procedures and documentation to assure a product has the identity, strength, composition, quality and purity that appear on the product label. These GMP requirements are listed FD&C Act section 520(f).

NPA and UL have developed a co-branded, dietary supplement-specific badge logo program for dietary supplements. The use of both the NPA and UL marks in its co-branded partnership are only available to companies certified under the NPA GMP standard with audits conducted by UL Registrar LLC.

This facility has been audited by UL Registrar LLC and meets GMP requirements listed in (RCP, NBCP, or Pharmaceutical, (NPA) Certification Schemes which is uniquely accredited by the American National Standard Institute (ANSI) developed in accordance with applicable sections of the FDA’s code of federal regulations.

Additional Certifications & Accreditations

2021 Declaration of Compliance with US Bioterrorism Law of 2002
CQC HACCP Certificate
2021 Declaration of Doping Free
AHPA Certificate of Membership
UL Registrar-NPA Certificate of Inspection, 21 CFR Part 111
2021-2022 FDA Registration Certificate

2021 Statement of Compliance with Current Good Manufacturing Processes
Informed-Choice Certificate
Informed-Sport Certificate
Informed-Choice/Sport Registered Site Certificate
MMEC Audit Certificate
2021 Montana DPHHS Food Manufacturing License
UL Registrar-NPA Certificate of Conformance, National Brand Certification, 21 CFR Part 111

State of California Pet Food Production Registration
Declaration of USDA Program Compliance
2021-2022 DEA Controlled Substance Registration Certificate
Montana Board of Pharmacy License
HACCP Certificate
UL Registrar-NPA Certificate of Conformance, 21 CFR Part 111

Grants Received

2016 from the Montana Board of Research & Commercialization Technology "Transdermal Delivery of Nutraceuticals"
Grant Amount: $40,000.00

2015 from the Montana Board of Research & Commercialization Technology "Antilipidemic and anti-adipodicity impact of PTBP in mildly hyperlipidemic and overweight but otherwise healthy volunteers"
Grant Amount: $12,500.00

2014 from the Montana Board of Research & Commercialization Technology "KarboLyn A Unique Homopolysaccharide Compound for Glycogen Repletion in Athletes"
Grant Amount: $80,000.00

2010 from the Montana Board of Research & Commercialization Technology "Second Phase Clinical Trials of a Lypolytic Compound"
Grant Total: $25,000.00

2009 from the Montana Board of Research & Commercialization Technology

2010 from the Montana Board of Research & Commercialization Technology "Clinical Trials of a Lypolytic Compound"
Grant Total $10,000.00

2008 from the Montana Board of Research & Commercialization Technology "Initial Clinical Pilot Trials and First-to-Market for Lipo-Effect , An all natural, non-prescription (OTC) designed to positively impact physiological Triglyceride & Cholesterol levels in humans".
Grant Total: $20,000.00

2007 from the Montana Board of Research & Commercialization Technology "Second Stage Field Clinical Trials & Bringing to Market of a Natural OTC ("Kre-Celazine") to Treat Chronic Inflammation".
Grant Total: $139,763.00